Pollogen Receives CE Mark for TriFractionalâ„¢ – An Advanced Anti-Aging Technology
Exclusively on the Maximus complete anti-aging platform, TriFractional enables deep, effective fractional skin resurfacing Ã¢“ an in-demand aesthetic treatment
Tel-Aviv, Israel (PRWEB) September 22, 2011
Pollogen announced today that it has received the Medical CE Mark for its TriFractional product, a fractional skin resurfacing technology based on radiofrequency. Treatments with TriFractional technology work on all skin types, penetrate to the mid-dermis for substantial skin renewal, cause minimal damage to the epidermis and enable the patients to easily schedule in this lunch-time procedure. TriFractional is effective for the reduction of wrinkle, scars – including acne scars – and pigmentation, as it also improves the texture and firmness of the skin.
An innovation on other fractional products, the TriFractional applicator uses a special algorithm to introduce radiofrequency energy to the skin which enables deep penetration to the mid-dermis with minimal discomfort, for one of the most effective fractional skin resurfacing treatments. The TriFractional RF energy creates tiny wounds which trigger the bodyÃ¢s natural healing response mechanism, inducing neocollagenesis and creating healthy skin cells. After the treatment, the untreated areas in the skin layers function as healing centers.
TriFractional is an add-on module to PollogenÃ¢s flagship multi-application Maximus platform, adding fractional technology to PollogenÃ¢s leading proprietary technologies Ã¢“ TriLipo Radiofrequency (RF) and TriLipo Dynamic Muscle Activation (DMA). Using these three technologies, the Maximus platform enables physicians to treat four layers of tissue: epidermis, dermis, muscles and fat, which no other single aesthetic device is able to do. The wide range of skin applications for both the face and body possible with Maximus, include wrinkle reduction, improved appearance of acne scars, firmed and rejuvenated skin, facial contouring, skin tightening, cellulite reduction, long-lasting circumferential reduction, stretch mark improvement and lifting, toning and firming of muscles.
Alex Levenberg, M.D., from the Physicians Center, Plastic Surgery Department in Tel Aviv, Israel, commented: “I have been using Pollogen’s Maximus with the new TriFractional applicator and the results I’ve seen on my patients are impressive. IÃ¢ve used the TriFractional solution for treating wrinkles, acne scars and improving skin complexion with a high degree of patient satisfaction. The treatment is quick and the results can be seen after one treatment.”
Pollogen’s CEO, Mr. Amichai Bar-Nir, stated, “Pollogen is pleased to receive the CE Mark for TriFractional, it is aligned with our strategy to consistently introduce compelling new products to our customers. The Maximus platform has been very well received in the 60 countries in which Pollogen products are sold and we expect the TriFractional module for this platform to enhance sales, since it answers patientsÃ¢ demand for a fast and effective anti-aging procedure that does not interrupt their daily routine.Ã¢
Pollogen Ltd. Is a global leader in the medical aesthetic market providing innovative, safe and effective solutions for women and men that enhance the practicesÃ¢ of medical aesthetic professionals. The company offers products to address a range of skin treatments under the industryÃ¢s three premier brands: TriPollar®, TriLipo® and TriFractionalÃ¢“¢.
Pollogen offers a full line of clinically-proven, non-invasive anti-aging facial and body contouring treatment platforms for wrinkle treatment, skin tightening, acne scarring, circumference reduction and cellulite reduction. PollogenÃ¢s medical aesthetic devices, Maximus, apollo, and regen XL offer customers clinically-proven, safe and effective anti-aging lunchtime beauty treatments that deliver immediate and long-lasting results, With a distribution network in over 60 countries, Pollogen is providing innovative solutions to medical professionals globally.
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebTriFractional-by-Pollogen/TriLipo-MED/prweb8806332.htm